Research map: TET2 downregulation limits oxidative stress-induced cytotoxicity of high dose ascorbate in dabrafenib-resistant melanoma cells

Back to the article

Papers in this map

  1. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis · Zefang Tang · 2019 · 5612 citations · Cited by this paper
  2. KLF5 promotes tumor proliferation and oxaliplatin resistance via chromatin remodeling in KRAS-mutated colorectal cancer · 2025 · Related
  3. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice · Qi Chen · 2008 · 863 citations · Cited by this paper
  4. Immunotherapy resistance and strategies in malignant pleural mesothelioma · 2026 · Related
  5. Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma · Christine Guo Lian · 2012 · 814 citations · Cited by this paper
  6. Effects of FAP+ cancer-associated fibroblasts on anti-PD-1 immunotherapy and CD4+ T cell polarization in gastric cancer · 2025 · Related
  7. Glucose Transporter Isoforms GLUT1 and GLUT3 Transport Dehydroascorbic Acid · Steven C. Rumsey · 1997 · 475 citations · Cited by this paper
  8. TRAP1 ablation improves mitochondrial cristae and oxidative phosphorylation in pancreatic cancer stem cells · 2026 · Related
  9. Ascorbate Induces Ten-Eleven Translocation (Tet) Methylcytosine Dioxygenase-mediated Generation of 5-Hydroxymethylcytosine · Emily A. Minor · 2013 · 424 citations · Cited by this paper
  10. Novel anti-tumor strategies: targeting the crosstalk between cancer stem cells and cancer-associated fibroblasts to resist drug resistance · 2026 · Related
  11. TET (Ten-eleven translocation) family proteins: structure, biological functions and applications · Xinchao Zhang · 2023 · 287 citations · Cited by this paper
  12. Unveiling the role of UGT enzymes in chemoresistance: a path to enhanced cancer pharmacotherapy · 2026 · Related
  13. Erythrocyte Glut1 Triggers Dehydroascorbic Acid Uptake in Mammals Unable to Synthesize Vitamin C · Amélie Montel‐Hagen · 2008 · 248 citations · Cited by this paper
  14. Targeting tumor-draining lymph node to overcome resistance to cancer immunotherapy: an update · 2025 · Related
  15. A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma · Y.N. Vashisht Gopal · 2019 · 98 citations · Cited by this paper
  16. Corosolic acid increases the therapeutic effect of cisplatin on gastric cancer by regulating Gpx4-dependent ferroptosis · 2025 · Related
  17. Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors · Raeeka Khamari · 2018 · 87 citations · Cited by this paper
  18. ROS1 mutations promote an immunosuppressive tumor microenvironment via MYC to confer immune evasion in head and neck cancer · 2025 · Related
  19. The Role of Vitamin C in Cancer Prevention and Therapy: A Literature Review · Marcelo Villagrán · 2021 · 76 citations · Cited by this paper
  20. Roles and potential applications of non-coding RNAs in cancer treatment with immune checkpoint inhibitors and immunomodulatory therapies · 2026 · Related
  21. Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor · Simona Caporali · 2016 · 75 citations · Cited by this paper
  22. The oxidized form of vitamin C, dehydroascorbic acid, regulates neuronal energy metabolism · Pedro Cisternas · 2014 · 74 citations · Cited by this paper
  23. Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation · Yun‐Xin Lu · 2018 · 69 citations · Cited by this paper
  24. Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia · Yihong Guan · 2020 · 57 citations · Cited by this paper
  25. Determinants of resistance and response to melanoma therapy · Bailey M. Robertson · 2024 · 51 citations · Cited by this paper
  26. High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients · Manuela Giansanti · 2021 · 49 citations · Cited by this paper
  27. Vitamin C promotes decitabine or azacytidine induced DNA hydroxymethylation and subsequent reactivation of the epigenetically silenced tumour suppressor CDKN1A in colon cancer cells · Christian Gerecke · 2018 · 45 citations · Cited by this paper
  28. The ROS ‐induced cytotoxicity of ascorbate is attenuated by hypoxia and HIF ‐1alpha in the NCI 60 cancer cell lines · Tobias W. Sinnberg · 2013 · 42 citations · Cited by this paper
  29. TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression · Elise Bonvin · 2018 · 33 citations · Cited by this paper
  30. BRAF Mutant Melanoma Adjusts to BRAF/MEK Inhibitors via Dependence on Increased Antioxidant SOD2 and Increased Reactive Oxygen Species Levels · Long Yuan · 2020 · 33 citations · Cited by this paper
  31. 5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma · Gerald S. Saldanha · 2016 · 26 citations · Cited by this paper
  32. Realigned transsulfuration drives BRAF-V600E-targeted therapy resistance in melanoma · Klaudia Borbényi-Galambos · 2025 · 22 citations · Cited by this paper
  33. Epigenetic Mechanisms Underlying Melanoma Resistance to Immune and Targeted Therapies · Andrey Rubanov · 2022 · 17 citations · Cited by this paper
  34. 5-Hydroxymethylcytosine: a key epigenetic mark in cancer and chemotherapy response · Suhas S. Kharat · 2025 · 14 citations · Cited by this paper
  35. Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C · Manuela Giansanti · 2021 · 11 citations · Cited by this paper
  36. Exploring the Ascorbate Requirement of the 2-Oxoglutarate-Dependent Dioxygenases · Carlos C. Smith-Díaz · 2025 · 10 citations · Cited by this paper
  37. Identification of Structural Determinants of the Transport of the Dehydroascorbic Acid Mediated by Glucose Transport GLUT1 · Marcelo Villagrán · 2023 · 9 citations · Cited by this paper
  38. Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors · Federica Ruffini · 2023 · 8 citations · Cited by this paper
  39. Divergent BRAF Inhibitor Resistance Mechanisms Revealed through Epigenetic Mapping · Yuanyuan Kang · 2022 · 6 citations · Cited by this paper

Source: OpenAlex (CC0)